Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
82.05
+8.17 (11.06%)
Real-time:   10:33AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 73.57 - 82.05
52 week 56.27 - 82.05
Open 73.57
Vol / Avg. 348,285.00/1.45M
Mkt cap 11.79B
P/E 23.49
Div/yield 0.38/1.85
EPS 3.49
Shares 144.00M
Beta 0.64
Inst. own 98%
Jul 22, 2015
Q2 2015 Quest Diagnostics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 15, 2015
Quest Diagnostics Inc Annual Shareholders Meeting
Apr 23, 2015
Q1 2015 Quest Diagnostics Inc Earnings Release
Apr 23, 2015
Q1 2015 Quest Diagnostics Inc Earnings Call - Webcast
Mar 31, 2015
Quintiles Transnational Holdings Inc and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services Call
Mar 11, 2015
Quest Diagnostics Inc at Barclays Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 3.81% 7.90%
Operating margin 12.40% 13.22%
EBITD margin - 18.04%
Return on average assets 2.74% 6.24%
Return on average equity 5.73% 13.31%
Employees 45,000 -
CDP Score - 83 C

Address

3 Giralda Farms
MADISON, NJ 07940
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. The Company’s operations are organized in two business groups, such as diagnostics information services and diagnostic solutions. Its diagnostics information services business is the provider of clinical testing services, gene-based, esoteric and anatomic pathology testing services and forensic drugs-of-abuse testing services. Its diagnostic solutions include Healthcare information technology, clinical trials testing, life insurer services and diagnostic products. The Company’s diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. It offers a range of solutions, including urine, hair, blood and oral fluid tests.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 60
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 48
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 52
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 52
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
John C. Baldwin M.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Jenne K. Britell Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters